Medicare (CMS) August 26th 2018 Local Coverage Determination (LCD) Updates

Centers for Medicare & Medicaid Services (CMS) Local Coverage Determination (LCD) Updates »

August 26th Medicare (CMS) 2018 LCD Updates:

• L37800               Allergen Immunotherapy
• A56116               Allergen immunotherapy – new Part B LCD
• A56116               Allergen immunotherapy – new Part B LCD
• A56117               Allergen Immunotherapy Coding Guidelines
• A52715 (retired)  Alpha1-Proteinase Inhibitor [Human] Billing Clarification
• L33420               Bladder/Urothelial Tumor Markers
• L34635               Botulinum Toxin Type A & Type B
• L35490               Category III Codes
• L37193               Coenzyme Q10 Testing
• L35121               Coronary Computed Tomography Angiography (CCTA)
• L33571 (retired)  Destruction of Internal Hemorrhoid(s) by Infrared Coagulation (IRC)
• A52377               Erythropoiesis Stimulating Agents (ESA) – Supplemental Instructions Article
• L36404               Foot Care
• A52427               Iron Sucrose, Iron Dextran and Ferumoxytol, (Intravenous Iron Therapy)
• A52753               Maintenance Programs
• A56110               Maintenance Programs
• A55738               MolDX: Coding and Billing for Abbott RealTime IDH2 testing for Acute Myeloid Leukemia (AML)
• A54187               MolDX: Avise PG Assay Billing/Coding Update
• A54187               MolDX: Avise PG Assay Billing/Coding Update
• L35631               MolDX: Breast Cancer Index℠ Genetic Assay
• DL37913             MolDX: Breast Cancer IndexTM (BCI) Gene Expression Test
• DL37917             MolDX: clonoSEQ® Assay for Assessment of Minimal Residual Disease (MRD) in Patients with Specific Lymphoid Malignancies
• DL37911             MolDX: Decipher® Biopsy Prostate Cancer Classifier Assay for Men with Very Low and Low Risk Disease
• L37356               MolDX: EndoPredict Breast Cancer Gene Expression Test
• DL37919             MolDX: Envisia, Veracyte, Idiopathic Pulmonary Fibrosis Diagnostic Test
• L36117               MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease
• L36793               MolDX: Genetic Testing for Lynch Syndrome
• L36153               MolDX: Genomic Health™ Oncotype DX® Prostate Cancer Assay
• L37649               MolDX: Guardant360^® Plasma-Based Comprehensive Genomic Profiling in Non-Small Cell Lung Cancer (NSCLC)
• L37651               MolDX: Guardant360^® Plasma-Based Comprehensive Genomic Profiling in Non-Small Cell Lung Cancer (NSCLC)
• L37671               MolDX: Guardant360® Plasma-Based Comprehensive Genomic Profiling in Non-Small Cell Lung Cancer (NSCLC)
• L37699               MolDX: Guardant360® Plasma-Based Comprehensive Genomic Profiling in Non-Small Cell Lung Cancer (NSCLC)
• DL37921             MolDX: Inivata, InVisionFirst, Liquid Biopsy for Patients with Lung Cancer
• DL37923             MolDX: myPath Melanoma Assay
• DL37915             MolDX: Oncotype DX AR-V7 Nucleus Detect for Men with Metastatic Castrate Resistant Prostate Cancer (MCRPC)
• L36912               MolDX: Oncotype DX® Breast Cancer for DCIS (Genomic Health™)
• L37354               MolDX: Oncotype DX® Genomic Prostate Score for Men with Favorable Intermediate Risk Prostate Cancer
• L37667               MolDX: Oncotype DX® Genomic Prostate Score for Men with Favorable Intermediate Risk Prostate Cancer
• A55200               MolDX: PIK3CA Gene Tests Coding and Billing Guidelines
• L35869               MolDX: Prolaris™ Prostate Cancer Genomic Assay
• L35869               MolDX: Prolaris™ Prostate Cancer Genomic Assay
• A52932 (retired)  Molecular Genetic testing
• A52942 (retired)  Molecular Genetic Testing
• A52754               Non-Payment for Prefabricated Splints
• A56112               Non-Payment for Prefabricated Splints
• L35486               Pelvic Floor Dysfunction: Anorectal Manometry and EMG
• L36000               Percutaneous minimally invasive fusion/stabilization of the sacroiliac joint for the treatment of back pain
• A56107               Response to Comments: MolDX: Guardant360® Plasma-Based Comprehensive Genomic Profiling in Non-Small Cell Lung Cancer (NSCLC)
• A56118               Response to Comments: DL37800 Allergen Immunotherapy
• A56091               Response to Comments: MolDX: Guardant360® Plasma-Based Comprehensive Genomic Profiling in Non-Small Cell Lung Cancer (NSCLC)
• A56092               Response to Comments: MolDX: Guardant360® Plasma-Based Comprehensive Genomic Profiling in Non-Small Cell Lung Cancer (NSCLC)
• A56114               Response to Comments: MolDX: Prolaris™ Prostate Cancer Genomic Assay
• L34760               Scanning Computerized Ophthalmic Diagnostic Imaging (SCODI)
• L34624               Somatosensory Testing
• A55739               Special Stains and Immunohistochemistry (IHC) Indications for Gastric Pathology
• A52723 (retired)  Updated Unlisted E/M Service CPT Code 99499
• A52764 (retired)  Vestibular Rehabilitation

Centers for Medicare & Medicaid Services (CMS) Local Coverage Determination (LCD) Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.